Literature DB >> 16249533

Does diabetes care compete with the provision of women's preventive care services?

Bahman P Tabaei1, William H Herman, Annissa F Jabarin, Catherine Kim.   

Abstract

OBJECTIVE: Care for chronic diseases may compete with preventive health care. To test this hypothesis, we examined the association between diabetes-related processes of care and preventive care in women. RESEARCH DESIGN AND METHODS: Using data from a prospective cohort study of diabetes care in managed care settings, we reviewed the care 540 diabetic women received from 355 primary care providers within 14 provider groups from one health plan. Of the 540 women, 278 were eligible to receive mammograms and 314 were eligible to receive Pap smears. Mammography performance was measured as at least one mammogram over a 2-year period and Pap performance was measured as at least one Pap smear over a 3-year period. To assess the association between diabetes-related processes of care and preventive services, we used hierarchical logistic regression models, accounted for clustering within provider groups, and adjusted for patient age, race, income and education level, diabetes treatment and duration, and health status, as well as physician age, sex, years of practice, and specialty. Diabetes-related processes of care were defined as dilated retinal examinations, urine microalbumin/protein testing, foot examinations, lipid and HbA(1c) testing, recommendations to take aspirin, and influenza vaccinations received over a 1-year period.
RESULTS: In this cohort, 73% of eligible women received mammograms and 56% received Pap smears. After adjustment of models, better diabetes-related processes of care, better health status, and non-Medicaid insurance were associated with mammography performance. Better diabetes-related processes of care, younger patient age, and any visit to a gynecologist were associated with Pap performance.
CONCLUSIONS: Better processes of diabetes care were associated with better women's preventive health care. Diabetes management did not compete with sex-specific screening.

Entities:  

Mesh:

Year:  2005        PMID: 16249533     DOI: 10.2337/diacare.28.11.2644

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Diabetes and differences in detection of incident invasive breast cancer.

Authors:  Gregory S Calip; Onchee Yu; Denise M Boudreau; Huibo Shao; Ruth Oratz; Stephen B Richardson; Heather T Gold
Journal:  Cancer Causes Control       Date:  2019-04-04       Impact factor: 2.506

Review 2.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

3.  Breast and cervical cancer screening specific effects of depression and obesity.

Authors:  Evette J Ludman; Laura E Ichikawa; Gregory E Simon; Paul Rohde; David Arterburn; Belinda H Operskalski; Jennifer A Linde; Robert W Jeffery
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

4.  Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.

Authors:  Kirsten Erickson; Ruth E Patterson; Shirley W Flatt; Loki Natarajan; Barbara A Parker; Dennis D Heath; Gail A Laughlin; Nazmus Saquib; Cheryl L Rock; John P Pierce
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

5.  Differences in Breast Cancer Screening Practices by Diabetes Status and Race/Ethnicity in the United States.

Authors:  Sydney E Kim; Alexandra E Bachorik; Kimberly A Bertrand; Christine M Gunn
Journal:  J Womens Health (Larchmt)       Date:  2021-12-17       Impact factor: 3.017

6.  Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes.

Authors:  Guixiang Zhao; Earl S Ford; Indu B Ahluwalia; Chaoyang Li; Ali H Mokdad
Journal:  J Gen Intern Med       Date:  2008-12-17       Impact factor: 5.128

7.  Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.

Authors:  Heather T Gold; Huibo Shao; Ruth Oratz; Onchee Yu; Marilyn Hammer; Stephen Richardson; Denise Boudreau
Journal:  Am J Clin Oncol       Date:  2020-02       Impact factor: 2.787

8.  Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes.

Authors:  Rodrigo Jiménez-Garcia; Valentin Hernandez-Barrera; Pilar Carrasco-Garrido; Angel Gil
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

9.  Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients.

Authors:  Cynthia Villarreal-Garza; Robin Shaw-Dulin; Fernando Lara-Medina; Ludwing Bacon; Daniel Rivera; Lorena Urzua; Christian Aguila; Rebeca Ramirez-Morales; Julieta Santamaria; Enrique Bargallo; Alejandro Mohar; Luis A Herrera
Journal:  Exp Diabetes Res       Date:  2012-07-31

10.  Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.

Authors:  Panayotis Constantinou; Rosemary Dray-Spira; Gwenn Menvielle
Journal:  BMC Cancer       Date:  2016-03-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.